0 223

Cited 0 times in

Rebamipide ameliorates hepatic dysfunction induced by ischemia/reperfusion in rats

DC Field Value Language
dc.contributor.author김경환-
dc.date.accessioned2021-12-27T17:16:49Z-
dc.date.available2021-12-27T17:16:49Z-
dc.date.issued1995-12-
dc.identifier.issn0014-2999-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/186521-
dc.description.abstractThe relationship between lipid peroxidation and alterations in hepatic secretory function and microsomal function during hepatic ischemia/reperfusion was studied. Rats pretreated with free radical scavengers were subjected to 60 min of hepatic ischemia and to 1 and 5 h of reperfusion thereafter. Serum aminotransferase level and microsomal lipid peroxidation were markedly increased by ischemia/reperfusion. These increases were significantly attenuated by rebamipide, α-tocopherol or allopurinol. Bile flow and cholate output were markedly decreased by ischemia/reperfusion and free radical scavengers, especially rebamipide, restored their secretion. NADPH-cytochrome P450 reductase activity and cytochrome P450 content were decreased by ischemia/reperfusion. Rebamipide prevented the decrease of the NADPH-cytochrome P450 reductase activity but had little effect on the cytochrome P450 content. AminopyrineN-demethylase activity was decreased and anilinep-hydroxylase was increased by ischemia/reperfusion, which were prevented by α-tocopherol and allopurinol, but not by rebamipide. Our findings suggest that ischemia/reperfusion diminishes hepatic secretory function and microsomal function by increasing lipid peroxidation, and rebamipide significantly ameliorates these changes through its free radical scavenging activity.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier Science-
dc.relation.isPartOfEUROPEAN JOURNAL OF PHARMACOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAlanine / analogs & derivatives*-
dc.subject.MESHAlanine / therapeutic use-
dc.subject.MESHAlanine Transaminase / blood-
dc.subject.MESHAllopurinol / pharmacology-
dc.subject.MESHAnimals-
dc.subject.MESHBile / drug effects-
dc.subject.MESHBile / metabolism-
dc.subject.MESHEnzyme Inhibitors / pharmacology-
dc.subject.MESHFree Radical Scavengers / pharmacology-
dc.subject.MESHLipid Peroxidation / drug effects-
dc.subject.MESHLiver Diseases / drug therapy*-
dc.subject.MESHLiver Diseases / pathology-
dc.subject.MESHMale-
dc.subject.MESHMicrosomes, Liver / drug effects-
dc.subject.MESHMicrosomes, Liver / enzymology-
dc.subject.MESHMixed Function Oxygenases / metabolism-
dc.subject.MESHNADPH-Ferrihemoprotein Reductase / metabolism-
dc.subject.MESHOrgan Size / drug effects-
dc.subject.MESHQuinolones / therapeutic use*-
dc.subject.MESHRats-
dc.subject.MESHRats, Sprague-Dawley-
dc.subject.MESHReperfusion Injury / drug therapy*-
dc.subject.MESHReperfusion Injury / pathology-
dc.subject.MESHVitamin E / pharmacology-
dc.subject.MESHXanthine Oxidase / antagonists & inhibitors-
dc.titleRebamipide ameliorates hepatic dysfunction induced by ischemia/reperfusion in rats-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pharmacology (약리학교실)-
dc.contributor.googleauthorSun-Mee Lee-
dc.contributor.googleauthorKyung Hwan Kim-
dc.identifier.doi10.1016/0014-2999(95)00507-2-
dc.contributor.localIdA00311-
dc.relation.journalcodeJ00842-
dc.identifier.eissn1879-0712-
dc.identifier.pmid8788414-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/0014299995005072-
dc.contributor.alternativeNameKim, Kyung Hwan-
dc.contributor.affiliatedAuthor김경환-
dc.citation.volume294-
dc.citation.number1-
dc.citation.startPage41-
dc.citation.endPage46-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF PHARMACOLOGY, Vol.294(1) : 41-46, 1995-12-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pharmacology (약리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.